Innoviva (INVA) Net Margin Growth (3y) (2014 - 2026)
Innoviva (INVA) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | -169,724.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -169,724.00 |
| Dec 31, 2025 | -6,217.00 |
| Sep 30, 2025 | -7,022.00 |
| Jun 30, 2025 | 4,065.00 |
| Mar 31, 2025 | -76,146.00 |
| Dec 31, 2024 | 327,960.00 |
| Sep 30, 2024 | -8,875.00 |
| Jun 30, 2024 | -328,337.00 |
| Mar 31, 2024 | -453,062.00 |
| Dec 31, 2023 | -2.22 Mn |
| Sep 30, 2023 | 2,080.00 |
| Jun 30, 2023 | -5,206.00 |
| Mar 31, 2023 | 180,449.00 |
| Dec 31, 2022 | -157,361.00 |
| Sep 30, 2022 | 4,575.00 |
| Jun 30, 2022 | -3,601.00 |
| Mar 31, 2022 | 64,767.00 |
| Dec 31, 2021 | -486,810.00 |
| Sep 30, 2021 | 1,357.00 |
| Jun 30, 2021 | 316,722.00 |